This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Jianwei Shen: Innovator in Pharmaceutical Compounds
Introduction
Jianwei Shen is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.
Latest Patents
Jianwei Shen holds a patent for the polymorphic form of a compound, specifically methyl (3R,6S)-6-amino-sulfonylamino-1-(thiazol-2-yl)-3-(2,3,4-trifluorophenyl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-4-formate. This patent outlines the preparation method and uses of this compound, which is crucial for developing effective pharmaceutical compositions. The patent highlights the importance of polymorphic forms in enhancing the efficacy and stability of pharmaceutical products.
Career Highlights
Jianwei Shen is associated with Qilu Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry. His role at the company has allowed him to focus on innovative research and development, contributing to the advancement of medical science. His dedication to his work is evident in the quality and impact of his inventions.
Collaborations
Jianwei has collaborated with esteemed colleagues such as Jin Zhang and Long Li. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and innovations.
Conclusion
Jianwei Shen's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts underscore his importance as an inventor. His work continues to influence the development of new therapeutic solutions, making a significant impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile